Global Klebsiella Pneumoniae Infection Drug Market Professional Survey Report 2018

Published: Jan, 2018 | Pages: 114 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report studies Klebsiella Pneumoniae Infection Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Acies Bio doo
    Appili Therapeutics
    Debiopharm International SA
    Evaxion Biotech ApS
    F. Hoffmann-La Roche Ltd
    FOB Synthesis Inc
    ImmunoClin Corp
    Innovation Pharmaceuticals Inc
    Kyorin Pharmaceutical Co Ltd
    Melinta Therapeutics Inc
    Nosopharm SAS
    Peptilogics Inc
    Pfizer Inc
    Phico Therapeutics Ltd
    Sarepta Therapeutics Inc
    Shionogi & Co Ltd
    Syntiron LLC
    Tetraphase Pharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ATI-1503
    CA-824
    CC-1807
    Cefiderocol
    Debio-1454
    EBX-004
    Others

By Application, the market can be split into
    Hospital
    Clinic
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Klebsiella Pneumoniae Infection Drug Market Professional Survey Report 2017
1 Industry Overview of Klebsiella Pneumoniae Infection Drug
    1.1 Definition and Specifications of Klebsiella Pneumoniae Infection Drug
        1.1.1 Definition of Klebsiella Pneumoniae Infection Drug
        1.1.2 Specifications of Klebsiella Pneumoniae Infection Drug
    1.2 Classification of Klebsiella Pneumoniae Infection Drug
        1.2.1 ATI-1503
        1.2.2 CA-824
        1.2.3 CC-1807
        1.2.4 Cefiderocol
        1.2.5 Debio-1454
        1.2.6 EBX-004
        1.2.7 Others
    1.3 Applications of Klebsiella Pneumoniae Infection Drug
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
    2.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
    2.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug

3 Technical Data and Manufacturing Plants Analysis of Klebsiella Pneumoniae Infection Drug
    3.1 Capacity and Commercial Production Date of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016

4 Global Klebsiella Pneumoniae Infection Drug Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Klebsiella Pneumoniae Infection Drug Capacity and Growth Rate Analysis
        4.2.2 2016 Klebsiella Pneumoniae Infection Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Klebsiella Pneumoniae Infection Drug Sales and Growth Rate Analysis
        4.3.2 2016 Klebsiella Pneumoniae Infection Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Klebsiella Pneumoniae Infection Drug Sales Price
        4.4.2 2016 Klebsiella Pneumoniae Infection Drug Sales Price Analysis (Company Segment)

5 Klebsiella Pneumoniae Infection Drug Regional Market Analysis
    5.1 North America Klebsiella Pneumoniae Infection Drug Market Analysis
        5.1.1 North America Klebsiella Pneumoniae Infection Drug Market Overview
        5.1.2 North America 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.1.4 North America 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis
    5.2 China Klebsiella Pneumoniae Infection Drug Market Analysis
        5.2.1 China Klebsiella Pneumoniae Infection Drug Market Overview
        5.2.2 China 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.2.4 China 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis
    5.3 Europe Klebsiella Pneumoniae Infection Drug Market Analysis
        5.3.1 Europe Klebsiella Pneumoniae Infection Drug Market Overview
        5.3.2 Europe 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.3.4 Europe 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis
    5.4 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Analysis
        5.4.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Overview
        5.4.2 Southeast Asia 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.4.4 Southeast Asia 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis
    5.5 Japan Klebsiella Pneumoniae Infection Drug Market Analysis
        5.5.1 Japan Klebsiella Pneumoniae Infection Drug Market Overview
        5.5.2 Japan 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.5.4 Japan 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis
    5.6 India Klebsiella Pneumoniae Infection Drug Market Analysis
        5.6.1 India Klebsiella Pneumoniae Infection Drug Market Overview
        5.6.2 India 2012-2017E Klebsiella Pneumoniae Infection Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price Analysis
        5.6.4 India 2016 Klebsiella Pneumoniae Infection Drug Market Share Analysis

6 Global 2012-2017E Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Klebsiella Pneumoniae Infection Drug Sales by Type
    6.2 Different Types of Klebsiella Pneumoniae Infection Drug Product Interview Price Analysis
    6.3 Different Types of Klebsiella Pneumoniae Infection Drug Product Driving Factors Analysis
        6.3.1 ATI-1503 of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.2 CA-824 of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.3 CC-1807 of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.4 Cefiderocol of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.5 Debio-1454 of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.6 EBX-004 of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        6.3.7 Others of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis

7 Global 2012-2017E Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Klebsiella Pneumoniae Infection Drug Consumption by Application
    7.2 Different Application of Klebsiella Pneumoniae Infection Drug Product Interview Price Analysis
    7.3 Different Application of Klebsiella Pneumoniae Infection Drug Product Driving Factors Analysis
        7.3.1 Hospital of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        7.3.2 Clinic of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis
        7.3.3 Others of Klebsiella Pneumoniae Infection Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Klebsiella Pneumoniae Infection Drug
    8.1 Acies Bio doo
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Acies Bio doo 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Acies Bio doo 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.2 Appili Therapeutics
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Appili Therapeutics 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Appili Therapeutics 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.3 Debiopharm International SA
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Debiopharm International SA 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Debiopharm International SA 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.4 Evaxion Biotech ApS
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Evaxion Biotech ApS 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Evaxion Biotech ApS 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.5 F. Hoffmann-La Roche Ltd
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 F. Hoffmann-La Roche Ltd 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 F. Hoffmann-La Roche Ltd 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.6 FOB Synthesis Inc
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 FOB Synthesis Inc 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 FOB Synthesis Inc 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.7 ImmunoClin Corp
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 ImmunoClin Corp 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 ImmunoClin Corp 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.8 Innovation Pharmaceuticals Inc
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Innovation Pharmaceuticals Inc 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Innovation Pharmaceuticals Inc 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.9 Kyorin Pharmaceutical Co Ltd
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Kyorin Pharmaceutical Co Ltd 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Kyorin Pharmaceutical Co Ltd 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.10 Melinta Therapeutics Inc
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Melinta Therapeutics Inc 2016 Klebsiella Pneumoniae Infection Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Melinta Therapeutics Inc 2016 Klebsiella Pneumoniae Infection Drug Business Region Distribution Analysis
    8.11 Nosopharm SAS
    8.12 Peptilogics Inc
    8.13 Pfizer Inc
    8.14 Phico Therapeutics Ltd
    8.15 Sarepta Therapeutics Inc
    8.16 Shionogi & Co Ltd
    8.17 Syntiron LLC
    8.18 Tetraphase Pharmaceuticals Inc

9 Development Trend of Analysis of Klebsiella Pneumoniae Infection Drug Market
    9.1 Global Klebsiella Pneumoniae Infection Drug Market Trend Analysis
        9.1.1 Global 2017-2022 Klebsiella Pneumoniae Infection Drug Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Klebsiella Pneumoniae Infection Drug Sales Price Forecast
    9.2 Klebsiella Pneumoniae Infection Drug Regional Market Trend
        9.2.1 North America 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
        9.2.2 China 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
        9.2.3 Europe 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
        9.2.5 Japan 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
        9.2.6 India 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Forecast
    9.3 Klebsiella Pneumoniae Infection Drug Market Trend (Product Type)
    9.4 Klebsiella Pneumoniae Infection Drug Market Trend (Application)

10 Klebsiella Pneumoniae Infection Drug Marketing Type Analysis
    10.1 Klebsiella Pneumoniae Infection Drug Regional Marketing Type Analysis
    10.2 Klebsiella Pneumoniae Infection Drug International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Klebsiella Pneumoniae Infection Drug by Region
    10.4 Klebsiella Pneumoniae Infection Drug Supply Chain Analysis

11 Consumers Analysis of Klebsiella Pneumoniae Infection Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Klebsiella Pneumoniae Infection Drug Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures
    Figure Picture of Klebsiella Pneumoniae Infection Drug
    Table Product Specifications of Klebsiella Pneumoniae Infection Drug
    Table Classification of Klebsiella Pneumoniae Infection Drug
    Figure Global Production Market Share of Klebsiella Pneumoniae Infection Drug by Type in 2016
    Figure ATI-1503 Picture
    Table Major Manufacturers of ATI-1503
    Figure CA-824 Picture
    Table Major Manufacturers of CA-824
    Figure CC-1807 Picture
    Table Major Manufacturers of CC-1807
    Figure Cefiderocol Picture
    Table Major Manufacturers of Cefiderocol
    Figure Debio-1454 Picture
    Table Major Manufacturers of Debio-1454
    Figure EBX-004 Picture
    Table Major Manufacturers of EBX-004
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Klebsiella Pneumoniae Infection Drug
    Figure Global Consumption Volume Market Share of Klebsiella Pneumoniae Infection Drug by Application in 2016
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Klebsiella Pneumoniae Infection Drug by Regions
    Figure North America Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Figure China Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Figure Europe Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Figure Japan Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Figure India Klebsiella Pneumoniae Infection Drug Market Size (Million USD) (2012-2022)
    Table Klebsiella Pneumoniae Infection Drug Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug in 2016
    Figure Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
    Figure Industry Chain Structure of Klebsiella Pneumoniae Infection Drug
    Table Capacity and Commercial Production Date of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Klebsiella Pneumoniae Infection Drug 2012-2017
    Figure Global 2012-2017E Klebsiella Pneumoniae Infection Drug Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Klebsiella Pneumoniae Infection Drug Market Size (Value) and Growth Rate
    Table 2012-2017E Global Klebsiella Pneumoniae Infection Drug Capacity and Growth Rate
    Table 2016 Global Klebsiella Pneumoniae Infection Drug Capacity (K Pcs) List (Company Segment)
    Table 2012-2017E Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate
    Table 2016 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) List (Company Segment)
    Table 2012-2017E Global Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Table 2016 Global Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E 
    Figure North America 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Figure North America 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E 
    Figure China 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) 
    Figure China 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E
    Figure Europe 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Figure Europe 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E
    Figure Southeast Asia 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Figure Southeast Asia 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E
    Figure Japan 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Figure Japan 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Pcs) of Klebsiella Pneumoniae Infection Drug 2012-2017E
    Figure India 2012-2017E Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs)
    Figure India 2016 Klebsiella Pneumoniae Infection Drug Sales Market Share
    Table Global 2012-2017E Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type
    Table Different Types Klebsiella Pneumoniae Infection Drug Product Interview Price
    Table Global 2012-2017E Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application
    Table Different Application Klebsiella Pneumoniae Infection Drug Product Interview Price
    Table Acies Bio doo Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Acies Bio doo Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Acies Bio doo Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Appili Therapeutics Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Debiopharm International SA Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Evaxion Biotech ApS Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table F. Hoffmann-La Roche Ltd Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table FOB Synthesis Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table ImmunoClin Corp Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Innovation Pharmaceuticals Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Kyorin Pharmaceutical Co Ltd Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Melinta Therapeutics Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2016 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Business Region Distribution
    Table Nosopharm SAS Information List
    Table Peptilogics Inc Information List
    Table Pfizer Inc Information List
    Table Phico Therapeutics Ltd Information List
    Table Sarepta Therapeutics Inc Information List
    Table Shionogi & Co Ltd Information List
    Table Syntiron LLC Information List
    Table Tetraphase Pharmaceuticals Inc Information List
    Figure Global 2017-2022 Klebsiella Pneumoniae Infection Drug Market Size (K Pcs) and Growth Rate Forecast
    Figure Global 2017-2022 Klebsiella Pneumoniae Infection Drug Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Forecast
    Figure North America 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure China 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Europe 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Japan 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure India 2017-2022 Klebsiella Pneumoniae Infection Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Table Global Sales Volume (K Pcs) of Klebsiella Pneumoniae Infection Drug by Type 2017-2022
    Table Global Consumption Volume (K Pcs) of Klebsiella Pneumoniae Infection Drug by Application 2017-2022
    Table Traders or Distributors with Contact Information of Klebsiella Pneumoniae Infection Drug by Region

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.